Hostname: page-component-84b7d79bbc-l82ql Total loading time: 0 Render date: 2024-07-25T20:20:03.374Z Has data issue: false hasContentIssue false
  • English
  • Français

Nutrition and autism

Published online by Cambridge University Press:  11 September 2013

Get access

In a nutshell

There is good reason to believe nutrition is important in autism. Most likely links include: gut inflammation and lymph hypertrophy, probably with an immune cause (e.g. food allergy), oxidative stress, fatty acid and micronutrient imbalance.

Convincing RCT evidence using these factors in treatment is, however, much harder to find.

Type
Brief Report
Information
Arbor Clinical Nutrition Updates , Volume 241 , February 2006 , pp. 1 - 3
Copyright
Copyright © Cambridge University Press 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Keller, F. et al. The neurobiological context of autism. Mol Neurobiol. 2003 Aug;28(1):1–22.CrossRefGoogle ScholarPubMed
2. White, JF. Intestinal pathophysiology in autism. Exp Biol Med (Maywood). 2003 Jun;228(6):639–49.CrossRefGoogle ScholarPubMed
3. Hahn, A. et al. [Autism and metabolic disorders-a rational approach] Z Kinder Jugendpsychiatr Psychother. 2005 Oct;33(4):259–71.CrossRefGoogle Scholar
4. Erickson, CA. et al. Gastrointestinal Factors in Autistic Disorder: A Critical Review. J Autism Dev Disord. 2005 Nov 3;:1–15 Google ScholarPubMed
5. Wakefield, AJ. et al. The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. Eur J Gastroenterol Hepatol. 2005 Aug;17(8):827–36.CrossRefGoogle ScholarPubMed
6. DeFelice, ML. et al. Intestinal cytokines in children with pervasive developmental disorders. Am J Gastroenterol. 2003 Aug;98(8):1777–82.CrossRefGoogle ScholarPubMed
7. Parracho, HM. et al. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol. 2005 Oct;54(Pt 10):987–91.CrossRefGoogle ScholarPubMed
8. Brudnak, MA. Probiotics as an adjuvant to detoxification protocols. Med Hypotheses. 2002 May;58(5):382–5.CrossRefGoogle ScholarPubMed
9. Jass, JR. The intestinal lesion of autistic spectrum disorder. Eur J Gastroenterol Hepatol. 2005 Aug;17(8):821–2.CrossRefGoogle ScholarPubMed
10. Green, VA. et al. Internet survey of treatments used by parents of children with autism. Res Dev Disabil. 2006 Jan-Feb;27(1):70–84.CrossRefGoogle ScholarPubMed
11. Kidd, PM. Autism, an extreme challenge to integrative medicine. Part 2: medical management. Altern Med Rev. 2002 Dec;7(6):472–99.Google ScholarPubMed
12. Vojdani, A. et al. Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease. Clin Diagn Lab Immunol. 2004 May;11(3):515–24.Google ScholarPubMed
13. Wakefield, AJ. et al. Review article: the concept of entero-colonic encephalopathy, autism and opioid receptor ligands. Aliment Pharmacol Ther. 2002 Apr;16(4):663–74.CrossRefGoogle ScholarPubMed
14. Millward, C. et al. Gluten- and casein-free diets for autistic spectrum disorder. Cochrane Database Syst Rev. 2004;(2):CD003498.Google Scholar
15. Williams, KW. et al. Intravenous secretin for autism spectrum disorder. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003495.Google Scholar
16. Nye, C. et al. Combined vitamin B6-magnesium treatment in autism spectrum disorder. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD003497.Google Scholar
17. McGinnis, WR. Oxidative stress in autism. Altern Ther Health Med. 2004 Nov-Dec;10(6):22–36..Google ScholarPubMed
18. Pasca, SP. et al. High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autism. Life Sci. 2005 Nov 16; [Epub ahead of print]Google Scholar
19. Dolske, MC. et al. A preliminary trial of ascorbic acid as supplemental therapy for autism. Prog Neuropsychopharmacol Biol Psychiatry. 1993 Sep;17(5):765–74.CrossRefGoogle ScholarPubMed
20. Arnold, GL. et al. Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies. J Autism Dev Disord. 2003 Aug;33(4):449–54.CrossRefGoogle ScholarPubMed
21. McDougle, CJ. et al. Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry. 1996 Nov;53(11):993–1000.CrossRefGoogle ScholarPubMed
22. Bell, JG. et al. Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins Leukot Essent Fatty Acids. 2004 Oct;71(4):201–4.CrossRefGoogle ScholarPubMed
23. Bourre, JM. Dietary omega-3 Fatty acids and psychiatry: mood, behaviour, stress, depression, dementia and aging. J Nutr Health Aging. 2005;9(1):31–8.Google ScholarPubMed
24. Richardson, AJ. Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot Essent Fatty Acids. 2004 Apr;70(4):383–90.CrossRefGoogle ScholarPubMed
25. Mutter, J. et al. Mercury and autism: accelerating evidence? Neuro Endocrinol Lett. 2005 Oct;26(5):439–46.Google ScholarPubMed
26. Fido, A. et al. Toxic trace elements in the hair of children with autism. Autism. 2005 Jul;9(3):290–8.CrossRefGoogle ScholarPubMed
27. Ip, P. et al. Mercury exposure in children with autistic spectrum disorder: case-control study. J Child Neurol. 2004 Jun;19(6):431–4.CrossRefGoogle ScholarPubMed
28. Sandler, A. Placebo effects in developmental disabilities: implications for research and practice. Ment Retard Dev Disabil Res Rev. 2005;11(2):164–70.CrossRefGoogle ScholarPubMed